QUOTE AND NEWS
Benzinga  Sep 13  Comment 
SAN DIEGO and ZURICH, Switzerland, Sept. 13, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI) and Takeda Pharmaceuticals International GmbH jointly announced today that they have entered into an exclusive license agreement to...
Benzinga  Feb 15  Comment 
Apricus Biosciences, Inc. (Nasdaq: APRI) announced today that its wholly-owned subsidiary NexMed Inc. has signed with Sandoz, a division of Novartis, an exclusive collaboration for Germany to market Apricus Bio's VitarosĀ® drug for the treatment...
StreetInsider.com  Aug 31  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Equity+Offerings/NexMed+%28NEXM%29+Files+%246.5M+Mixed+Shelf/5936404.html for the full story.
StreetInsider.com  Aug 23  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/NexMed+%28NEXM%29+Announces+New+Additional+Patent+Coverage+for+Israel/5916264.html for the full story.
FierceBiotech  Jul 28  Comment 
Ambit Biosciences has completed a thorough executive search and appointed Alan Lewis as chairman and CEO of the company. Release Ablynx Chief Scientific Officer Debbie Law has resigned from her position at Ablynx. Release iBio has named...
StreetInsider.com  Jul 7  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/NexMed+%28NEXMD%29+Regains+NASDAQ+Compliance/5787074.html for the full story.
StreetInsider.com  Jun 24  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/NexMed+%28NEXMD%29+Gets+Patent+in+Japan+for+Vitaros/5757531.html for the full story.
StreetInsider.com  Jun 23  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Health+Canada+Confirms+NexMed%27s+%28NEXMD%29+Acceptance+of+CMC+for+Review+of+Vitaros/5754256.html for the full story.
Globe Newswire  Jun 21  Comment 
CALGARY, Alberta, June 21, 2010 (GLOBE NEWSWIRE) -- Emerging Stock Report, a leading provider of sector specific independent investment research, today initiated coverage on NexMed, Inc. (Nasdaq:NEXM). Emerging Stock Report is currently offering a
StreetInsider.com  Jun 18  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Stock+Splits/NexMed+%28NEXM%29+Announces+15-for-1+Reverse+Split/5742065.html for the full story.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki